CEPI opens Call to develop heat-stable vaccine tech for use against epidemic and pandemic threats
The Coalition for Epidemic Preparedness Innovations (CEPI) has launched a $17.5 million initiative to improve the thermostability of current and future vaccines.
Currently, cold chain requirements are one of the leading causes of global vaccine wastage. Improving the thermostability of vaccines will work to improve global access, especially in low-income countries.
CEPI’s Acting Director of Vaccine Manufacturing and Supply Chain, Ingrid Kromann said: “We’re really looking to see a step change in the way that some of these vaccines can be stored and delivered.”
To read the full article, follow the link below:
CEPI opens Call to develop heat-stable vaccine tech for use against epidemic and pandemic threats
The Conversation: Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccination
The COVID-19 pandemic has perpetuated rapid medical advancements and technological innovations. Over the last 20 months, we’ve experienced an influx of new vaccines which have proven to be safe and effective in preventing disease.
Scientists and researchers around the world are already working on the next generation of COVID vaccines to help tackle issues regarding waning immunity, storage and delivery, and vaccine hesitancy. Focusing their efforts on making vaccination easier, delivering more durable immunity and protecting against future variants
This article looks at the different considerations for research and technology around the world that will in turn lead to the next generation of COVID vaccines.
Follow the link to read the full article: Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccination